Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The RareCyte® platform for next‐generation analysis of circulating tumor cells

2 Oct 2018

Abstract excerpt

Circulating tumor cells (CTCs) can reliably be identified in cancer patients and are associated with clinical outcome. Next-generation "liquid biopsy" technologies will expand CTC diagnostic investigation to include phenotypic characterization and single-cell molecular analysis. We describe here a rare cell analysis platform designed to comprehensively collect and identify CTCs, enable multi-parameter assessment...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Cancer Genomics and Diagnostics
Share to Microfluidic and Bio-sensing Technologies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30277660
DOI: 10.1002/cyto.a.23619

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The RareCyte® platform for next‐generation analysis of circulating tumor cellsPMID 30277660Read ↗

High-recovery visual identification and single-cell retrieval of circulating tumor cells for genomic analysis using a dual-technology platform integrated with automated immunofluorescence stainingSemantic proximity Read ↗

Circulating tumor cells: Blood-based detection, molecular biology, and clinical applicationsSemantic proximity Read ↗

Future of Liquid Biopsies With Growing Technological and Bioinformatics Studies: Opportunities and Challenges in Discovering Tumor Heterogeneity With Single-Cell Level AnalysisSemantic proximity Read ↗

Single-cell analysis of circulating tumour cells: enabling technologies and clinical applicationsSemantic proximity Read ↗

GeTMoR: Simultaneous genomic, transcriptomic, and morphological profiling of rare single cellsSemantic proximity Read ↗

Liquid biopsy: one cell at a timeSemantic proximity Read ↗

Circulating Tumor Cell Enrichment and Single-Cell Isolation Combining the CellSearch® and DEPArray™ Systems.Semantic proximity Read ↗

Clinical Applications of and Challenges in Single-Cell Analysis of Circulating Tumor CellsSemantic proximity Read ↗

Circulating Tumor Cells: Clinically Relevant Molecular Access Based on a Novel CTC Flow CellSemantic proximity Read ↗

Single-Cell Analysis of Circulating Tumor Cells: Why Heterogeneity MattersSemantic proximity Read ↗

Liquid biopsy: current technology and clinical applicationsSemantic proximity Read ↗

Tumor cell-based liquid biopsy using high-throughput microfluidic enrichment of entire leukapheresis productSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.